EUVIMEDEUVIMED entdecken
Open Access

LncRNA FAM30A Predicts Adverse Prognosis and Regulates Cellular Processes in Colorectal Cancer via Modulating miR-21-3p

Guoxiang Ye, Yanxiang Chen

Turkish Journal of Gastroenterology · 2024

DOI: 10.5152/tjg.2024.23465 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Gastroenterology, 2024. Verfasst von Guoxiang Ye und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Friendliness Hospital Yangzhou, Yangzhou, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, MicroRNAs, RNA, Long Noncoding, Cell Proliferation. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: Colorectal cancer (CRC) is a prevalent gastrointestinal cancer with high incidence and mortality rate. lncRNAs could regulate the expression of miRNAs and further affect cancer development. Previous research has suggested that FAM30A is involved in various cancer. We aimed to investigate the function of FAM30A in the prognosis of CRC and its underlying molecular mechanisms. Materials and Methods: Matched tissues were collected from 107 CRC patients. FAM30A was measured by quantitative real-time transcription polymerase chain reaction and its clinical significance was evaluated by its correlation with patients’ prognosis and clinicopathological features. Furthermore, the dual luciferase reporter assays were employed to assess the interactions between FAM30A and miR-21-3p and to evaluate the role of miR-21-3p in regulating the tumor suppressor effects of FAM30A. Cell proliferation and metastasis were evaluated by the Transwell assay and cell counting kit-8 assay.

Results

FAM30A level was markedly decreased in CRC tissues (P < .001). A prominent association was observed in FAM30A with tumor– node–metastasis stage (P = .022), carcinoembryonic antigen (P = .027), and differentiation (P = .043) of CRC patients. The lower the FAM30A level was associated with the lower the survival rate of the CRC patients (log rank P = .034). FAM30A could negatively modulate miR-21-3p (P < .001), and the overexpression of FAM30A significantly suppressed CRC cell proliferation and metastasis (P < .001). The suppressive function of FAM30A overexpression was mediated by miR-21-3p.

Conclusion

FAM30A can be considered a poor prognostic indicator in CRC. Decreased FAM30A can promote the proliferation and metastasis of CRC cells by negatively regulating miR-21-3p. Cite this article as: Ye G, Chen Y. LncRNA FAM30A predicts adverse prognosis and regulates cellular processes in colorectal cancer via modulating miR-21-3p. Turk J Gastroenterol. 2024;35(7):532-538.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsMicroRNAsRNA, Long NoncodingCell ProliferationGene Expression Regulation, NeoplasticHumansMaleFemalePrognosisMiddle AgedCell Line, TumorAgedDown-Regulation

Substanzen

MicroRNAsRNA, Long NoncodingMIRN21 microRNA, human

Autor:innen und Institutionen

  • Department of Oncology, Friendliness Hospital Yangzhou, Yangzhou, China.

Zitieren

APA

Ye, G., & Chen, Y. (2024). LncRNA FAM30A Predicts Adverse Prognosis and Regulates Cellular Processes in Colorectal Cancer via Modulating miR-21-3p. Turkish Journal of Gastroenterology. https://doi.org/10.5152/tjg.2024.23465

Vancouver

Ye G, Chen Y. LncRNA FAM30A Predicts Adverse Prognosis and Regulates Cellular Processes in Colorectal Cancer via Modulating miR-21-3p. Turkish Journal of Gastroenterology. 2024. doi:10.5152/tjg.2024.23465

BibTeX
@article{Ye2024,
  author = {Ye, Guoxiang and Chen, Yanxiang},
  title = {LncRNA FAM30A Predicts Adverse Prognosis and Regulates Cellular Processes in Colorectal Cancer via Modulating miR-21-3p},
  journal = {Turkish Journal of Gastroenterology},
  year = {2024},
  doi = {10.5152/tjg.2024.23465}
}
Kostenlos starten →